GeneTex
  • Country / Location Selection

United States (US)

Cancer Tissue Gallery- GTX04415

Inhibin alpha antibody [MSVA-561R] HistoMAX

 

Go to Normal Tissue Gallery Go back to product page Go to HistoMAX page

 

Adrenal gland – Strong INHA immunostaining in all cells of an adrenocortical adenoma.
Adrenal gland – Strong INHA immunostaining in an adrenocortical carcinoma. Immunostaining is reduced in an area of necrosis.
Adrenal gland – Strong INHA immunostaining in most cells of an adrenocortical adenoma. A fraction of cells do not stain, however (mosaic pattern).
Adrenal gland – Weak to moderate INHA immunostaining about 70% of the cells of an adrenocortical adenoma.
Breast – INHA negative invasive breast cancer of no special type (NST).
Colon – Colorectal adenocarcinoma with focal weak to moderat INHA immunostaining (<5% of cells).
Esophagus – INHA negative esophageal squamous cell carcinoma.
Kidney – INHA negative clear cell renal cell carcinoma.
Kidney – Moderate to strong INHA immunostaining in a clear cell renal cell carcinoma.
Larynx – INHA negative squamous cell carcinoma.
Liver – Moderate to strong INHA immunostaining in about 50% of the tumor cells of a cholangiocellular carcinoma.
Lung – Strong INHA positivity in an adenocarcinoma of the lung.
Ovary – INHA negative serous high-grade carcinoma. Scattered stroma cells show strong INHA positivity.
Pancreas – INHA negative adenocarcinoma.
Pancreas – Moderate to strong INHA immunostaining in a pancreatic acinar cell carcinoma.
Pancreas – Strong INHA immunostaining in the vast majority of the tumor cells of a neuroendocrine tumor.
Penis – INHA positivity of variable intensity (mosaic pattern) in a penile squamous cell carcinoma.
Prostate – INHA negative prostatic adenocarcinoma (Gleason 3+3=6).
Skin – INHA negative Merkel cell carcinoma.
Soft tissues – Granular cell tumor with strong INHA immunostaining.
Stomach – INHA negative gastric adenocarcinoma.
Testis – INHA negative seminoma.
Thyroid – INHA negative papillary carcinoma.
Urinary bladder – INHA negative muscle-invasive urothelial carcinoma.
Urinary bladder – Muscle-invasive urothelial carcinoma with focal strong INHA immunostaining (<5% of cells).
     

| TOP |